Trial intelligence / Profile preview

Blood glucose control with BC222 insulin lispro compared to Humalog after a standardized meal

2014-005028-92Phase 2Completed

Sponsor
Adocia
Start
Dec 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of human insulin and BioChaperone Lispro in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Adocia. Primary endpoint: AUCBG,0-2h. Started Dec 2014; status: completed.

02

Drugs

human insulinBioChaperone Lispro
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2014-005028-92.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005028-92.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call